Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, now has more treatment options than ever before. From early detection to advanced systemic therapies, this episode explores how doctors personalize care to improve survival and quality of life for HCC patients. In this episode, you’ll learn: How imaging tools like MRI and CT improve early detection of liver cancer Why are alpha-fetoprotein (AFP) blood tests important for diagnosis and monitoring Which patients qualify for surgery, liver resection, or liver transplant How local therapies like ablation (RFA) and chemoembolization work for intermediate-stage HCC The role of systemic therapies, immunotherapy, and targeted drugs in advanced cases How combined therapy is improving survival rates for advanced HCC Why clinical trials are expanding treatment options and patient access to new medicines This episode highlights the most effective HCC treatment strategies available today, helping patients and families understand their options and what to expect. Blog Link: New Approaches for Treating Hepatocellular Carcinoma Send us a text Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education. Author: Dr. CHRISTINA NG VAN TZE 📍 Visit us at oncolifecentre.com 📞 Call: +603-2242-2620 📧 Book a consultation or ask a question — we're here to support your journey.
